Peter W. Sonsini's Net Worth

$11.2 Thousand

Who is Peter W. Sonsini?

Peter W. Sonsini does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., MULESOFT, INC, Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., Oyster Point Pharma, Inc., AVEO PHARMACEUTICALS INC, APPIAN CORP, Mersana Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, IonQ, Inc., Nightstar Therapeutics plc, Loxo Oncology, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Reneo Pharmaceuticals, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Galera Therapeutics, Inc., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Annexon, Inc., Mirna Therapeutics, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., IMARA Inc., Marker Therapeutics, Inc., Casper Sleep Inc., ZeroFox Holdings, Inc., Senti Biosciences, Inc.\, Strongbridge Biopharma plc, Achaogen Inc, Tintri, Inc., and INTERLEUKIN GENETICS INC.

SEC CIK

Peter W. Sonsini's CIK is 0001559807

Past Insider Trading and Trends

2020 was Peter W. Sonsini's most active year for acquiring shares with 2 total transactions. Peter W. Sonsini's most active month to acquire stocks was the month of January. 2020 saw Peter W. Sonsini paying a total of $0.00 for 745 shares, this is the most they've acquired in one year.